Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

AstraZeneca dedicates resources to discovery of safe neuroprotective compounds

Feb. 14, 2001

Effects of BMP-7 in rats with transient MCA occlusion discussed at this week's stroke conference

Feb. 14, 2001

Adjunctive treatment with Cerebrolysin associated with neuroprotection in acute ischemic stroke

Feb. 14, 2001

IL-1ra protects cortical neurons following transient middle cerebral artery occlusion

Feb. 14, 2001

Nonsedating anxiolytic agents reported by Egis

Feb. 13, 2001

Advance in treatment, diagnosis of prion diseases patented by Canadian researchers

Feb. 13, 2001

Anti-TNF-alpha antisense strategy proves beneficial in rat model of ICH

Feb. 13, 2001

Small study provides preliminary evidence for efficacy of modafinil in ADHD

Feb. 13, 2001

Use of pregabalin restricted in certain clinical trial patients

Feb. 13, 2001

European patent issued to Pfizer for new opioid receptor antagonists

Feb. 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.